PharmaForceIQ acquires Aktana, launches first “optichannel-in-a-box” platform for pharma
The integration unifies brand and field strategy, drives executional alignment, and delivers immediate impact measurement
The integration unifies brand and field strategy, drives executional alignment, and delivers immediate impact measurement
DME is among the most challenging retinal diseases to treat and has long served as a proving ground for therapies that ultimately become first-line standard of care in retinal diseases
InflaRx is streamlining operations and largely discontinuing non-essential activities outside izicopan’s development
After leading AstraZeneca's Oncology areas nationally and internationally, Laura Colón will assume the presidency of AstraZeneca in one of its priority global markets
The partnership builds on a prior collaboration between Nimbus and Lilly targeting AMPK in cardiometabolic diseases
The therapy was well tolerated through Week 24, with a safety profile consistent with Alumis’ Phase 2 data
Fasting glucose improved by 12.3 mg/dL, while liver stiffness dropped 23.7%, signaling a direct hepatic benefit
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
Under the agreement, Insilico could receive up to $32 million in upfront and near-term R&D payments
The FDA acknowledged that Corcept’s pivotal GRACE trial met its primary endpoint and that data from the GRADIENT trial offered confirmatory evidence
Subscribe To Our Newsletter & Stay Updated